Purchase Articles
Showing 81–96 of 145 results
-
Clinical Duty to Recontact in Genetic Testing: Insights from the Safety-Related Duty to Recall
$20.00 Add to cart -
Patented drug prices and clinical trials in 31 OECD countries 2017: implications for Canada’s PMPRB.
Read Article -
HTA and public coverage of new mental health drugs in Quebec and Canada.
$20.00 Add to cart -
Medical resources and spending across provincial healthcare systems in Canada.
$20.00 Add to cart -
Medical Resources in Canada and OECD countries. 2019 Edition.
$20.00 Add to cart -
Close the Gaps: Patient Benefits and Taxpayer Costs of 3 Pharmacare Options
Read Article -
Evidence that innovative medicines improve health and economic outcomes: focused literature review.
Read Article -
Pan-Canadian Pharmaceutical Alliance negotiations 2014-2018
$20.00 Add to cart -
Out-of-pocket prescription drug costs: What are the implications for National Pharmacare?
Read Article -
Taxpayer Cost of National Pharmacare: Disputing the Parliamentary Budget Officer’s Estimate
$20.00 Add to cart -
Coverage of new medicines in Federal-Provincial public drug plans in Canada 2008-2017
$20.00 Add to cart -
Coverage of new medicines in public versus private drug plans in Canada 2008-2017
$20.00 Add to cart -
New Patented Medicine Regulations in Canada: Case Study of a Manufacturer’s Decision-Making
Read Article -
Prescription drug plan coverage 2016: how many Canadians were insured, under-insured or uninsured?
$20.00 Add to cart -
Comparing expert representation on HTA advisory committees in Canada, the UK and Australia
$20.00 Add to cart -
Facts about the cost of patented drugs in Canada: 2018 Edition.
Read Article